Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3

(2010) A Chakrabarty et al.   ONCOGENE

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer

(2008) S. Jain et al.   CANCER RESEARCH

Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer

(2008) Y. Liu et al.   CANCER RESEARCH

Cytosolic Phospholipase A2- : A Potential Therapeutic Target for Prostate Cancer

(2008) M. I. Patel et al.   CLINICAL CANCER RESEARCH